Company Filing History:
1 out of 340 
1 out of 1 Years Active: 2025
Title: Eyal Weinstock: Innovator in Bacteriophage Therapy
Introduction
Eyal Weinstock is a notable inventor based in Kfar Shmaryahu, Israel. He has made significant contributions to the field of medical science, particularly in the area of bacteriophage therapy. His innovative work focuses on addressing inflammatory bowel disease through the use of bacteriophage compositions.
Latest Patents
Eyal Weinstock holds a patent for a bacteriophage designed to modulate inflammatory bowel disease. The patent discloses compositions and therapeutic uses of bacteriophage that can effectively lyse bacterial strains associated with this condition. This groundbreaking approach has the potential to transform treatment options for patients suffering from inflammatory bowel disease.
Career Highlights
Throughout his career, Eyal Weinstock has worked with esteemed institutions, including Keio University and Biomx Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in bacteriophage research.
Collaborations
Eyal has collaborated with notable professionals such as Kenya Honda and Koji Atarashi. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Eyal Weinstock's innovative contributions to bacteriophage therapy highlight his commitment to advancing medical science. His patent and collaborations reflect a dedication to improving treatment options for inflammatory bowel disease.